Goldman Sachs’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.61M Buy
62,450
+27,026
+76% +$698K ﹤0.01% 3552
2025
Q1
$361K Sell
35,424
-13,068
-27% -$133K ﹤0.01% 4428
2024
Q4
$676K Sell
48,492
-70,404
-59% -$982K ﹤0.01% 4134
2024
Q3
$2.32M Buy
118,896
+1,063
+0.9% +$20.7K ﹤0.01% 3265
2024
Q2
$2.19M Buy
117,833
+70,479
+149% +$1.31M ﹤0.01% 3137
2024
Q1
$664K Sell
47,354
-10,237
-18% -$143K ﹤0.01% 3842
2023
Q4
$488K Sell
57,591
-10,840
-16% -$91.9K ﹤0.01% 3968
2023
Q3
$611K Sell
68,431
-18,394
-21% -$164K ﹤0.01% 3797
2023
Q2
$749K Buy
86,825
+16,690
+24% +$144K ﹤0.01% 3774
2023
Q1
$739K Sell
70,135
-2,131
-3% -$22.5K ﹤0.01% 3863
2022
Q4
$2.45M Sell
72,266
-1,242
-2% -$42.1K ﹤0.01% 3144
2022
Q3
$3.53M Buy
73,508
+26,716
+57% +$1.28M ﹤0.01% 2927
2022
Q2
$2.67M Buy
46,792
+14,029
+43% +$800K ﹤0.01% 3211
2022
Q1
$2.65M Buy
32,763
+5,710
+21% +$462K ﹤0.01% 3344
2021
Q4
$5.48M Sell
27,053
-3,569
-12% -$723K ﹤0.01% 2724
2021
Q3
$8.25M Sell
30,622
-10,470
-25% -$2.82M ﹤0.01% 2418
2021
Q2
$10.6M Buy
41,092
+10,427
+34% +$2.68M ﹤0.01% 2209
2021
Q1
$9.2M Sell
30,665
-37,951
-55% -$11.4M ﹤0.01% 2263
2020
Q4
$17.5M Buy
68,616
+6,226
+10% +$1.59M ﹤0.01% 1662
2020
Q3
$15.5M Sell
62,390
-48,696
-44% -$12.1M ﹤0.01% 1653
2020
Q2
$38.6M Sell
111,086
-9,844
-8% -$3.42M 0.01% 1042
2020
Q1
$32.4M Sell
120,930
-9,332
-7% -$2.5M 0.01% 1048
2019
Q4
$42.2M Buy
130,262
+44,142
+51% +$14.3M 0.01% 1133
2019
Q3
$23.5M Buy
86,120
+28,248
+49% +$7.72M 0.01% 1422
2019
Q2
$30.9M Buy
57,872
+5,069
+10% +$2.71M 0.01% 1318
2019
Q1
$26.6M Sell
52,803
-5,630
-10% -$2.84M 0.01% 1428
2018
Q4
$28.8M Sell
58,433
-17,967
-24% -$8.86M 0.01% 1300
2018
Q3
$69.9M Sell
76,400
-19,912
-21% -$18.2M 0.02% 892
2018
Q2
$70.5M Sell
96,312
-3,866
-4% -$2.83M 0.02% 889
2018
Q1
$160M Buy
100,178
+57,969
+137% +$92.4M 0.04% 484
2017
Q4
$37.8M Sell
42,209
-21,059
-33% -$18.9M 0.01% 1221
2017
Q3
$22.8M Buy
63,268
+9,979
+19% +$3.59M 0.01% 1502
2017
Q2
$15.6M Buy
53,289
+10,393
+24% +$3.05M ﹤0.01% 1692
2017
Q1
$15.1M Buy
42,896
+10,893
+34% +$3.83M ﹤0.01% 1657
2016
Q4
$5.89M Sell
32,003
-24,019
-43% -$4.42M ﹤0.01% 2087
2016
Q3
$14.4M Buy
56,022
+29,714
+113% +$7.66M ﹤0.01% 1644
2016
Q2
$5.62M Buy
26,308
+1,846
+8% +$394K ﹤0.01% 2065
2016
Q1
$5.05M Sell
24,462
-6,349
-21% -$1.31M ﹤0.01% 2061
2015
Q4
$7.79M Buy
30,811
+5,456
+22% +$1.38M ﹤0.01% 1807
2015
Q3
$4.17M Sell
25,355
-4,468
-15% -$734K ﹤0.01% 2122
2015
Q2
$5.6M Sell
29,823
-7,929
-21% -$1.49M ﹤0.01% 2011
2015
Q1
$6.23M Buy
37,752
+16,087
+74% +$2.65M ﹤0.01% 1908
2014
Q4
$5.04M Buy
21,665
+1,206
+6% +$280K ﹤0.01% 1982
2014
Q3
$3.7M Sell
20,459
-3,187
-13% -$577K ﹤0.01% 2166
2014
Q2
$4.55M Buy
23,646
+3,021
+15% +$581K ﹤0.01% 2063
2014
Q1
$3.75M Buy
20,625
+2,891
+16% +$526K ﹤0.01% 2183
2013
Q4
$3.02M Sell
17,734
-7,267
-29% -$1.24M ﹤0.01% 2347
2013
Q3
$3.92M Buy
25,001
+5,823
+30% +$912K ﹤0.01% 2068
2013
Q2
$3.32M Buy
+19,178
New +$3.32M ﹤0.01% 2019